CompuGroup Medical SE & Co. KGaA (COP.DE)
EUR 22.14
(0.18%)
EUR 22.14
(0.18%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.23 Billion EUR | -3.14% |
| 2022 | 1.27 Billion EUR | 7.81% |
| 2021 | 1.17 Billion EUR | 27.16% |
| 2020 | 926.83 Million EUR | 15.0% |
| 2019 | 805.94 Million EUR | 40.09% |
| 2018 | 575.31 Million EUR | -2.32% |
| 2017 | 588.94 Million EUR | -0.05% |
| 2016 | 589.25 Million EUR | -1.64% |
| 2015 | 599.06 Million EUR | 7.21% |
| 2014 | 558.8 Million EUR | 11.88% |
| 2013 | 499.44 Million EUR | 5.84% |
| 2012 | 471.87 Million EUR | -0.13% |
| 2011 | 472.51 Million EUR | 26.45% |
| 2010 | 373.67 Million EUR | 40.5% |
| 2009 | 265.95 Million EUR | 13.41% |
| 2008 | 234.5 Million EUR | 180.19% |
| 2007 | 83.69 Million EUR | -49.5% |
| 2006 | 165.74 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.32 Billion EUR | 0.92% |
| 2024 Q1 | 1.31 Billion EUR | 7.01% |
| 2023 Q2 | 1.24 Billion EUR | -0.23% |
| 2023 Q1 | 1.24 Billion EUR | -1.63% |
| 2023 FY | 1.23 Billion EUR | -3.14% |
| 2023 Q4 | 1.23 Billion EUR | -0.36% |
| 2023 Q3 | 1.23 Billion EUR | -0.95% |
| 2022 Q1 | 1.23 Billion EUR | 4.93% |
| 2022 Q3 | 1.28 Billion EUR | -1.84% |
| 2022 Q2 | 1.3 Billion EUR | 5.47% |
| 2022 FY | 1.27 Billion EUR | 7.81% |
| 2022 Q4 | 1.27 Billion EUR | -0.76% |
| 2021 Q2 | 1.1 Billion EUR | 11.62% |
| 2021 Q1 | 992 Million EUR | 7.03% |
| 2021 FY | 1.17 Billion EUR | 27.16% |
| 2021 Q3 | 1.15 Billion EUR | 4.24% |
| 2021 Q4 | 1.17 Billion EUR | 2.1% |
| 2020 FY | 926.83 Million EUR | 15.0% |
| 2020 Q1 | 838.93 Million EUR | 4.09% |
| 2020 Q2 | 803.05 Million EUR | -4.28% |
| 2020 Q3 | 793.92 Million EUR | -1.14% |
| 2020 Q4 | 926.83 Million EUR | 16.74% |
| 2019 Q4 | 805.94 Million EUR | 17.7% |
| 2019 FY | 805.94 Million EUR | 40.09% |
| 2019 Q3 | 684.75 Million EUR | -1.64% |
| 2019 Q1 | 699.25 Million EUR | 21.54% |
| 2019 Q2 | 696.18 Million EUR | -0.44% |
| 2018 Q2 | 608.18 Million EUR | -1.78% |
| 2018 FY | 575.31 Million EUR | -2.32% |
| 2018 Q1 | 619.18 Million EUR | 5.13% |
| 2018 Q4 | 575.31 Million EUR | -4.2% |
| 2018 Q3 | 600.54 Million EUR | -1.26% |
| 2017 Q3 | 575.39 Million EUR | -3.87% |
| 2017 Q2 | 598.54 Million EUR | -1.26% |
| 2017 Q1 | 606.17 Million EUR | 2.87% |
| 2017 FY | 588.94 Million EUR | -0.05% |
| 2017 Q4 | 588.94 Million EUR | 2.36% |
| 2016 Q4 | 589.25 Million EUR | -3.0% |
| 2016 Q1 | 609.92 Million EUR | 1.81% |
| 2016 Q2 | 608.34 Million EUR | -0.26% |
| 2016 FY | 589.25 Million EUR | -1.64% |
| 2016 Q3 | 607.47 Million EUR | -0.14% |
| 2015 Q1 | 601.78 Million EUR | 7.69% |
| 2015 FY | 599.06 Million EUR | 7.21% |
| 2015 Q4 | 599.06 Million EUR | 1.67% |
| 2015 Q3 | 589.24 Million EUR | -2.81% |
| 2015 Q2 | 606.3 Million EUR | 0.75% |
| 2014 Q4 | 558.8 Million EUR | 0.44% |
| 2014 Q3 | 556.33 Million EUR | 3.88% |
| 2014 Q1 | 544.29 Million EUR | 8.98% |
| 2014 Q2 | 535.56 Million EUR | -1.6% |
| 2014 FY | 558.8 Million EUR | 11.88% |
| 2013 Q2 | 472.33 Million EUR | -0.32% |
| 2013 Q3 | 485.43 Million EUR | 2.77% |
| 2013 Q4 | 499.44 Million EUR | 2.89% |
| 2013 FY | 499.44 Million EUR | 5.84% |
| 2013 Q1 | 473.83 Million EUR | 0.41% |
| 2012 Q1 | 512.24 Million EUR | 8.41% |
| 2012 Q3 | 464.2 Million EUR | -2.66% |
| 2012 FY | 471.87 Million EUR | -0.13% |
| 2012 Q4 | 471.87 Million EUR | 1.65% |
| 2012 Q2 | 476.87 Million EUR | -6.9% |
| 2011 Q2 | 471.84 Million EUR | 2.32% |
| 2011 Q3 | 462.58 Million EUR | -1.96% |
| 2011 Q4 | 472.51 Million EUR | 2.15% |
| 2011 FY | 472.51 Million EUR | 26.45% |
| 2011 Q1 | 461.14 Million EUR | 23.41% |
| 2010 Q2 | 267.3 Million EUR | 0.99% |
| 2010 Q3 | 346.48 Million EUR | 29.62% |
| 2010 FY | 373.67 Million EUR | 40.5% |
| 2010 Q4 | 373.67 Million EUR | 7.85% |
| 2010 Q1 | 264.67 Million EUR | -0.48% |
| 2009 Q4 | 265.95 Million EUR | 0.0% |
| 2009 FY | 265.95 Million EUR | 13.41% |
| 2008 FY | 234.5 Million EUR | 180.19% |
| 2007 FY | 83.69 Million EUR | -49.5% |
| 2006 FY | 165.74 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| DocCheck AG | 21.07 Million EUR | -5739.681% |
| MeVis Medical Solutions AG | 10.22 Million EUR | -11932.46% |
| Nexus AG | 153.13 Million EUR | -703.656% |